438
Participants
Start Date
June 3, 2019
Primary Completion Date
October 31, 2024
Study Completion Date
November 20, 2024
Atropine 0.1% Ophthalmic Solution
Atropine 0.1% ophthalmic solution administered with a microdose dispenser
Atropine 0.01% Ophthalmic Solution
Atropine 0.01% ophthalmic solution administered with a microdose dispenser
Placebo Ophthalmic Solution
Placebo ophthalmic solution administered with a microdose dispenser
SUNY College of Optometry, New York
Scott & Christie and Associates, Cranberry Township
Salus University - The Eye Institute, Philadelphia
Virginia Pediatric Eye Center, Virginia Beach
Wake Forest Health Network Ophthalmology - Oak Hollow, High Point
Oculus Research, Raleigh
University of Alabama at Birmingham School of Optometry, Birmingham
Primary Eyecare Group, Brentwood
Vanderbilt University Medical Center, Nashville
Southern College of Optometry, Memphis
The Ohio State University - College of Optometry, Columbus
Midwestern University, Downers Grove
Illinois College of Optometry, Chicago
Midwestern University, Glendale
Marshall Ketchum University College of Optometry, Los Angeles
Canyon City Eyecare, Azusa
Ratner Children's Eye Center, San Diego
UC Berkeley, Berkeley
Lead Sponsor
Eyenovia Inc.
INDUSTRY